BFS
Bradley Foster & Sargent’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,351
| Closed | -$219K | – | 430 |
|
|
2022
Q3 | $219K | Hold |
3,351
| – | – | 0.01% | 398 |
|
|
2022
Q2 | $204K | Hold |
3,351
| – | – | 0.01% | 424 |
|
|
2022
Q1 | $210K | Buy |
3,351
+600
| +22% | +$37.6K | ﹤0.01% | 451 |
|
|
2021
Q4 | $208K | Buy |
2,751
+160
| +6% | +$12.1K | ﹤0.01% | 434 |
|
|
2021
Q3 | $290K | Buy |
2,591
+10
| +0.4% | +$1.12K | 0.01% | 365 |
|
|
2021
Q2 | $418K | Buy |
2,581
+120
| +5% | +$19.4K | 0.01% | 326 |
|
|
2021
Q1 | $300K | Buy |
2,461
+11
| +0.4% | +$1.34K | 0.01% | 336 |
|
|
2020
Q4 | $375K | Buy |
+2,450
| New | +$375K | 0.01% | 319 |
|
|
2018
Q4 | – | Sell |
-9,460
| Closed | -$420K | – | 349 |
|
|
2018
Q3 | $420K | Buy |
+9,460
| New | +$420K | 0.01% | 297 |
|
|
2018
Q1 | – | Sell |
-11,765
| Closed | -$276K | – | 351 |
|
|
2017
Q4 | $276K | Buy |
+11,765
| New | +$276K | 0.01% | 317 |
|